SilPort Plus is an implantable port designed for vascular access applications. It is particularly beneficial in oncology treatments, improving patient experience and comfort during therapeutic procedures by providing reliable long-term venous access.
Manufactured by
Argentina
We are specialists in vascular access products, with a focus on Neonatology and Pediatrics, offering a complete line that contributes to patient well-being. Our international brand Silmag arrives in Brazil after 30 years of history in Latin America, together with the local brand Blenta, with a strong commitment to innovation and excellence in healthcare solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NPZ technology Ltd
United Kingdom · 1 relevant product
Zhengzhou DIALL Medical Technology Co., Ltd
China · 1 relevant product
Lexel SRL
Argentina · 2 relevant products
37 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 81 closest product alternatives
NPZ technology Ltd · United Kingdom
Implantable port system for vascular access enabling secure, repeated administration of chemotherapy, medications, and nutritional support. Designed for long-term intravenous therapy with reduced infection risk and improved patient comfort. Comprises titanium or plastic port chamber with attached catheter for subcutaneous placement.
Zhengzhou DIALL Medical Technology Co., Ltd · China
Implantable device providing long-term central venous access for repeated blood draws and medication administration. Vascular ports offer improved patient quality of life and reduced infection rates compared to external catheters.
Lexel SRL · Argentina
Implantable titanium port for vascular access in chemotherapy, parenteral nutrition, and long-term medication delivery. Subcutaneously placed device with needle-access septum enabling repeated venous catheterization while minimizing infection risk and patient discomfort. Titanium construction ensures biocompatibility and durability.
78 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products